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To evaluate the efficacy of cystoscopy, computed tomography (CT), transcavitary ultrasound (TCUS) and cytology,
separately and in combination, for the diagnosis and evaluation of superficial bladder cancer.
Initial cystoscopy and wash-out cytology were performed for 1548 patients. Of these, 206 with proven bladder
tumors were included in this prospective study. CT and TCUS were performed for patients with bladder tumors
without knowledge of their cystoscopy results. The lesions were classified as low- (pTa) and high- (pT1) risk
superficial tumors according to multiplicity and size.
Patients were divided into three categories according to their cystoscopically evaluated tumor size: ≤1 cm
(88 patients, 42.7%), 1–3 cm (51 patients, 24.8%) and ≥3 cm (67 patients, 32.5%). TCUS identified 46 (22.3%)
high-risk patients with/without invasion and 160 (77.7%) low-risk patients with no invasion. Overall, the sensitivity,
specificity, positive predictive value and negative predictive value of TCUS for tumor detection were 77.4%, 60%,
94.7% and 22.2%, respectively.
Cystoscopy remains the most widely used technique for the diagnosis of bladder cancer. The combined use of CT,
TCUS and cytology detected 72% of cystoscopically proven tumors. Among the three, TCUS findings exhibited the
strongest correlation with cystoscopy findings.
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Initial evaluation and staging are crucial for the manage-
ment of bladder cancer because the choice of curative
surgical intervention or alternative therapeutic options
depends on the extent of tumor invasion into the deeper
layers of the bladder wall. Pathological staging of trans-
urethral resection (TUR) is the gold standard for this
purpose. Imaging techniques such as ultrasonography,
computed tomography (CT) and magnetic resonance
imaging are often used to assess the clinical staging of pa-
tients. However, the stage determined by clinical evalu-
ation may be incorrect compared with the pathological* Correspondence: karadagmert@yahoo.com
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in any medium, provided the original work is pstage in as many as 50% of the patients (Skinner and
Lieskovsky 1988, Cummings et al. 1992). In general, high-
grade, intermediate-stage bladder tumors tend to be clin-
ically down-staged in almost a third of patients and
up-staged in 10% (See and Fuller 1992). Consequently,
patients who have been down-staged may be under-
treated, and those who have been up-staged may
undergo unnecessary treatments, with possible resulting
co-morbidities.
This prospective study aimed to evaluate the efficacy
of cystoscopy, computed tomography (CT), transcavitary
ultrasound (TCUS) and cytology, separately and in com-
bination, for the diagnosis and evaluation of superficial
bladder cancer compared with that of pathological
diagnosis.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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The study group comprised 177 males (85.9%) and 29
females (14.1%). The patients were divided into three
categories according to tumor size measured during
cystoscopy: ≤1 cm (88 patients, 42.7%), 1–3 cm (51 pa-
tients, 24.8%) and ≥3 cm (67 patients, 32.5%). The sizes
of the tumors were defined by total sum of the length of
the tumors which were evaluated by the surgeon intra-
operatively. CT imaging found no tumors in 78 patients
(37.9%), ≤1-cm tumors in 34 (16.5%), 1–3-cm tumors in
52 (25.2%) and ≥3-cm tumors in 42 (20.4%). Totally, 170
(82.5%) patients had no invasion and 36 (17.5%) had
invasive tumors according to CT findings.
TCUS detected no tumors in 54 patients (26.2%), ≤1-cm
tumors in 26 (12.6), 1–3 cm tumors in 80 (38.8%)
and >3 cm tumors in 46 (22.3%). TCUS evaluation
revealed invasion in 46 patients (22.3%) and no invasion
in 160 (77.7%). An overall summary of the size, invasion
and grade of the tumors is given in Table 1.
Cytological analysis showed benign cells in 130 pa-
tients (63.1%), malignant cells in 63 (30.6%), suspicious
cells in 7 (3.4%) and acellular findings in 6 (2.9%). Post-
TUR pathology showed benign lesions such as cystitis in
20 patients (9.7%), although the macroscopic appearance
resembled that of malignant neoplasms. The rate of pTa
tumors was 66% (136 patients), and that of ≥ pT1 tumors
was 24.2% (50 patients). Overall, 112 (54.4%) were low-
grade tumors and 74 (35.9%) were high-grade tumors.
Univariate analysis of variance for CT, TCUS and cyto-
logical findings, with cystoscopy findings as the
dependent variable, showed that CT and TCUS findings,
but not cytological findings, were statistically significant
factors (Pearson χ2 values: p = 0.001, p = 0.001 and p =
0.697 for CT, TCUS and cytology, respectively). The ad-
justed R2 value was 0.720, indicating that the combin-
ation of CT, cytology and TCUS was able to detect
findings similar to those of cystoscopy in 72% patients.
When CT and TCUS findings were compared because
they both correlated well with cystoscopy findings, theTable 1 The distribution and comparison of cases in terms of
Cystoscopy Patho
n (%) n (%)
Tumor size No tumor 0 (0)
≤ 1 cm 88 (42,7)
1-3 cm 51 (24,8)
≥ 3 cm 67 (32,5)
Invasion (benign or) – 191 (9
+1112121 15 (7,
Tumor - 20 (9,
low grade 112 (5
high grade 74 (35f values were 9.604 and 29.556, respectively. These re-
sults indicated that TCUS was a better tool compared
with CT for the evaluation and classification of bladder
tumors as low- or high-risk tumors.
Univariate analysis of variance was performed separ-
ately for CT and TCUS findings, again with cystoscopy
findings as the dependent variable. For TCUS, p was
0.001, f was 149,390 and R2 was 0.685 (68.5%), while for
CT, p was 0.001, f was 97,113 and R2 was 0.584 (58.4%).
These results showed that TCUS and CT findings corre-
lated with a rate of 68.5% and 58.4% to cystoscopy find-
ings, respectively. Therefore, TCUS appeared to be a
better imaging technique when compared with CT for
bladder tumor detection. Obviously, cystoscopy was
superior to both TCUS and CT (p = 0.001 for both).
The Spearman correlation test was used to assess the
correlation of CT, cytological and TCUS findings with
cystoscopy findings. Our results showed that all three
had independent statistical significance (p = 0.001 for
all). The correlation coefficients between cystoscopy and
CT, cystoscopy and TCUS, and cystoscopy and cytology
were 0.736, 0.814 and 0.297, respectively (Table 2).
These findings showed that the correlation of cyto-
logical findings with cystoscopy findings was low. The
CT results correlated well with those of cystoscopy, but
the correlation was significantly better for the TCUS
results.
Univariate analysis of variance for the CT and TCUS re-
sults with respect to stage, with the histopathological re-
sults as the dependent variable, showed that the invasion
detection values for CT were p = 0.030 and f = 4.771,
while those for TCUS were p = 0.001 and f = 25,588.
According to these findings, both CT and TCUS detected
invasion with statistical significance; however, TCUS
showed a stronger correlation (the f value was higher for
TCUS) compared with CT. The combination of TCUS
and CT identified high-risk or invasive tumors in 47.5%
patients. TCUS alone predicted invasion at the rate of
46.5%, which was statistically significant.size, invasion and grade
logy (TUR-BT) TRUS CT
n (%) n (%)
54 (26,2) 78 (37,9)
26 (12,6) 34 (16,5)
80 (38,8) 52 (25,2)
46 (22,3) 42 (20,4)
2,7) 160 (77.7%) 170 (82.5%)




Table 2 Spearman’s correlation test results to estimate
the association between cystoscopy, CT, cytology and
TCUS
Cystoscopy CT Cytology TRUS
Cystoscopy 0.736 0.297 0.814
r 0.001 0.001 0.001
n 206 206 206 206
CT 0.736 0.264 0.798
r 0.001 0.001 0.001
n 206 206 206 206
Cytology 0.297 0.264 0.358
r 0.001 0.001 0.001
n 206 206 206 206
TCUS 0.814 0.798 0.358
r 0.001 0.001 0.001
n 206 206 206 206
TCUS has the highest correlation with cystoscopy.
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the 136 pathologically proven pTa patients (67.6% detec-
tion rate); 87.5% were high-risk tumors. These findings
are consistent with previous findings showing that
cytology had higher sensitivity and specificity for the
detection of high-grade or high-stage patients.
A comparison of the pathological and TCUS results
showed that TCUS did not detect any tumors in 12/20
patients (60%) with no pathologically proven tumors,
whereas false-positive tumor detection occurred in 8/20
(40%) patients without malignant pathologies. On the
other hand, out of 186 pathologically proven bladder tu-
mors, TCUS was not able to detect 42 (22.6%) tumors,
whereas it identified 144 (77.4%) tumors (Pearson χ2 test
p = 0.001). The sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) of
TCUS for tumor detection were 77.4%, 60%, 94.7% and
22.2%, respectively. When the same analysis was per-
formed for CT, the sensitivity, specificity, PPV and NPV
were 66.7%, 80%, 96.6% and 20.5%.
Discussion
Accurate assessment of tumor extension in bladder can-
cer is critical for selecting the optimal treatment. TUR-
BT, together with pathological evaluation, is the gold
standard for this purpose, but there is still a need for
further clinical evaluation techniques. Clinical studies
have shown that TUR-BT alone has a sensitivity of 46%
and specificity of 67% for tumor staging (Yaman et al.
1996, Herr et al. 1990). Therefore, almost 50% of the
patients who are evaluated solely by TUR-BT are either
down- or up-staged. Consequently, many patients are
undertreated or undergo unnecessary treatments that
can result in a high morbidity rate. Inaccurate staging oftumors is the result of insufficient resection in the
majority of cases. New technologies such as photo-
dynamic systems have been used to try and improve the
sensitivity of cystoscopy (Kausch et al. 2010). However,
these systems are yet to be proven and are expensive.
Therefore, they have not yet been well adopted in daily
urological practice.
The reported accuracy of CT in the detection and
evaluation of bladder cancer varies from 64% to 97%,
whereas that in the detection of perivesical involvement
and lymph node metastases varies from 83% to 93% and
from 73% to 92%, respectively (Kim et al. 2004, Setty
et al. 2007). In our study, the accuracy of CT was 66.7%
in tumor size measurement and 68.8% in invasion detec-
tion. Our results correlate with those reported in the
literature (See and Fuller 1992, Voges et al. 1989). The
small discrepancies may be attributed to the limited
number of high-risk or invasive cancers in our series.
Baltaci et al. (2008), in a retrospective analysis of 100
bladder cancer patients, reported an accuracy of 57% for
CT findings, which were not supported by pathological
findings in 22 patients. In the same series, six patho-
logically proven cases of perivesical invasion were not
identified by CT. The authors concluded that CT was
statistically insignificant for the detection of extravesical
invasion in bladder tumors. New studies have reported
increased sensitivity of bladder tumor detection using
multiplanar high-resolution multidetector CT. Tumors
measuring <1 cm have been reportedly identified, par-
ticularly those on the base or dome of the bladder, with
these new techniques (Setty et al. 2007). In our study,
CT identified only 31.8% (28/88 patients) of tumors
measuring 1 cm, 74.5% (38/51 patients) of tumors
measuring 1–3 cm and 92.5% (62/67) of tumors measur-
ing >3 cm. As expected, the CT detection rate increased
with larger tumors. The sensitivity of CT scanning
for <1-cm tumors in our series was lower than that of
high-dose urography (See and Fuller 1992, Pollack 2000,
Klein and Pollack 1992). The low rate of tumor identifica-
tion may be attributed to suboptimal studies conducted in
the early phases of contrast enhancement, when the blad-
der is not completely engaged with contrast material.
Watanabe et al. (1983) reported the use of TRUS for
the detection of superficial bladder tumors, with an up-
staging rate of 48% and a down-staging rate of 5% for
invasive tumors. Yaman et al. (1996) reported a 40% over-
all accuracy of TRUS imaging for all stages of bladder
tumors. In the same series, the down- and up-staging
rates were reported to be 49% and 11%, respectively.
Caskurlu et al. (1998), in a study of TRUS for the diag-
nosis and staging of 38 bladder cancer patients, com-
pared transabdominal and transrectal ultrasound results
with CT results. In that cohort, the patients were classi-
fied as having superficial or invasive tumors. TRUS
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superficial and invasive group (sensitivity, 88.8% and
90%, respectively; specificity, 94.4% and 95%, respect-
ively). A recent article dealed with the potential role of
TRUS for diagnosis or recurrence detection in bladder
cancer (Fabiani et al. 2012). Depending on the results’ of
2 cases, the authors concluded that the use of TRUS for
bladder cancer detection was an easy, inexpensive and
accurate tool. In our series, the accuracy of TCUS for
evaluation and staging was 83.3%. The down- and up-
staging rates for TCUS in our series were 3.8% and 6.3%,
respectively. As in the case of CT, the diagnostic accuracy
of TCUS was directly correlated with tumor size. For
tumors measuring <1 cm, the detection rate remained
unsatisfactory.
Cytology is a minimally invasive method for bladder
tumor detection. However, because of operator depend-
ence, the nonspecificity in tumor localization because of
the nonspecific origin of malignant cells within the col-
lecting system from the kidneys to the urethra and the
low sensitivity, cytology has not gained popularity for
use in bladder cancer patients (Lotan and Roehrborn
2003). The atypical cell slough encountered during infec-
tions, urinary stones and intravesical instillations may
also cause difficulties in the interpretation of cytological
materials. In our series, the overall sensitivity of cytology
was very low (22.3%). The highest correlation between
cytology and cystoscopy was observed for high-grade
(47.3%) and large-volume tumors (56.7% for tumors
measuring >3 cm).
Conclusions
Cystoscopy remains the most widely used technique for
the diagnosis of bladder cancer patients. On comparison
with CT, TCUS and cytology showed that CT and TCUS
imaging were significantly beneficial, whereas cytology
was not. The combined use of all three techniques
resulted in a detection rate of 72% for cystoscopically
proven tumors. Among the three techniques, TCUS ex-
hibited the strongest correlation with cystoscopy. In the
evaluation and staging of bladder cancers, both CT and
TCUS results showed statistically significant correlations
with pathological results; however, TCUS was clearly su-
perior to CT. Incorrect down-staging occurred less often
with TCUS than with CT, whereas up-staging was com-
parable between techniques. For both CT and TCUS, the
detection rates improved as the tumor size increased.
With the more prevalent use and higher imaging qualities,
TCUS may become a good adjunct to cystoscopy. This
imaging technique is familiar to urologists, is less expen-
sive, is associated with a low morbidity rate and does not
require radiation exposure. We hope that the results of
this study will encourage urologists to use TCUS for the
detection and evaluation of bladder cancers.Methods
Our study was approved by local ethics committee of
Samatya Training and Research Hospital and performed
in accordance with the Helsinki Declaration of the
World Medical Association. All of the patients signed
and understood informed consent forms about study.
Initial cystoscopy and wash-out cytology were performed
in 1548 patients due to suspicious of bladder carcinoma
between 2008 and 2012 in Samatya Training and
Research Hospital. Of these, 206 with proven bladder
tumors were included in this prospective study. The
inclusion criteria of the study was patients with suspi-
cious of bladder cancer on the basis of the presence of
haematuria in whom cystoscopy revealed bladder cancer,
patients with urea < 50 mg/dl, creatinine < 1.3 mg/dl,
normal protrombin time and active partial tromboplas-
tin time, patients who had preoperative normal electro-
cardiography and chest X ray findings. The exclusion
criteria were compromised renal function (serum urea
level > 50 mg/dL or creatinine level > 1.5 mg/dL), abnor-
mal bleeding and clotting parameters and pathological
findings on electrocardiography or plain chest radiog-
raphy performed to avoid CT with contrast or anaesthe-
sia for TUR of bladder tumor (TUR-BT). In addition,
patients with any solid evidence of invasive bladder can-
cer (hydronephrosis in the upper urinary tract with no
other aetiology, abnormality in rectal or bimanual exam-
ination and clear demonstration of invasion on CT) were
excluded because the point of interest was non-muscle
invasive bladder cancer.
A late-phase, contrast induced, high-speed pelvic CT
(General High Speed CT, GE™ Medical Supplies, USA)
study with 5-mm intervals was performed for all patients
before TUR-BT. Tumor size and invasion degree on CT
were the study endpoints. Invasion degree was defined
as the extent of the tumor into the submucosa, muscular
and serozal layers of the bladder at CT. TCUS and CT
studies were performed on the day of hospital admission
and were performed by a radiologist and a urologist
blinded to the patients’ cystoscopy results. All patients
underwent standard TUR-BT using a Storz™ resecto-
scope (Storz™, Germany) and loops. Pathological evalu-
ation was performed by a single pathologist. On the
basis of clinical and pathological data, the tumors were
classified as low-risk (pTa), high-risk and invasive super-
ficial (pT1 and over) bladder cancer according to the
EAU guidelines (Babjuk et al. 2013).
Cystoscopy
A 17-F calibre rigid cystoscope with 30° and 70° angle
lenses and a lubricant that included 2% lidocain (Cathejell,
Taymed™, Istanbul, Turkey) was used for cystoscopy,
which was performed under local anaesthesia. The tumor
locations and sizes were noted. A wash-out cytological
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sent for evaluation.
TCUS
All of the procedures were performed by a TRUS
(Transrectal ultrasound)-certified urologist. In male
patients, local anaesthesia with 2% lidocaine (Cathejell)
gel was applied to the anus and rectal mucosa just
before the procedure. Bladder filling was adjusted to
300–500 cc. For female patients, a General Electric™
Logiq 200 (GE™ Medical Supplies, USA) with a 6.5-mHz
endocavitary probe was used to perform the same TCUS
procedure transvaginally. All of the probes were end fire
probes. An invasive tumor was characterized as disrup-
tion of the bladder wall and perivesical invasion in
TCUS imaging. All others were interpreted as superficial
tumors. In addition, the lesions were defined as low- or
high-risk superficial bladder cancer with respect to the
size or multiplicity of the tumor. Single tumors measur-
ing <3 cm were assumed to be low-risk tumors, while
others were assumed to be high-risk tumors on imaging.
Due to the reason that in situ carcinoma cannot be diag-
nosed by using these modalities, the presence of this
type of tumor was not considered as a risk factor.
Pearson’s χ2 test was used to perform categorical
analysis, and Spearman’s correlation test was used to
determine correlations. For further evaluations, univari-
ate analysis of variance, the paired t-test, the Kruskall–
Wallis test and the Mann–Whitney-U tests were used.
Abbreviations
CT: Computed tomography; TCUS: Transcavitary ultrasound; TUR: Transurethral
resection; TUR-BT: Transurethral resection for bladder tumor.
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